ArticleUltrasonography (Seoul, Korea)2026
Kupffer-phase Sonazoid ultrasound LI-RADS for liver cancer: diagnostic performance and algorithm modification.
Article in Ultrasonography (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to enhance the noninvasive identification of hepatocellular carcinoma (HCC) by modifying the Sonazoid-based contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) through integration of Kupffer-phase (KP) imaging and optimization of washout timing criteria.
methodsThis retrospective two-center study enrolled 558 patients with solitary liver nodules who underwent Sonazoid-based CEUS between August 2022 and September 2024. CEUS features were assessed according to LI-RADS v2017 using predefined washout time windows (2, 5, and 10 minutes). A modified LI-RADS algorithm incorporating KP hypoenhancement was developed. Interobserver agreement was evaluated using the Cohen kappa. Diagnostic performance metrics (area under the curve [AUC], sensitivity, specificity, and positive predictive value) were compared between the modified CEUS LI-RADS algorithms and the Japan Society of Hepatology (JSH) and Korean Liver Cancer Association (KLCA) guidelines using the McNemar and DeLong tests.
resultsFor key CEUS features, interobserver agreement was moderate to almost perfect (κ=0.580-0.815). The modified CEUS LI-RADS-10min algorithm demonstrated superior performance over the other algorithms. By reclassifying LR-M nodules with early washout and mild KP hypoenhancement as LR-5, the modified CEUS LI-RADS-10min algorithm achieved the highest diagnostic performance for HCC (AUC, 0.782), improving sensitivity while maintaining specificity (73.7%). Its performance was comparable to that of the KLCA guideline. The JSH guidelines showed the highest sensitivity (91.7%) but the lowest specificity (53.9%).
conclusionIntegrating KP hypoenhancement with a 10-minute washout window improves the sensitivity of Sonazoid-based CEUS LI-RADS for diagnosing HCC while preserving specificity, providing feasible refinement aligned with established guidelines and promoting standardization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.